FDA allows emergency use of antibody drug Trump received


PTI, Nov 22, 2020, 10:17 AM IST

Washington: US health officials have agreed to allow emergency use of a second antibody drug to help the immune system fight COVID-19, an experimental medicine that President Donald Trump was given when he was sickened last month.

The Food and Drug Administration authorised use of the Regeneron Pharmaceuticals Inc. drug on Saturday to try to prevent hospitalisation and worsening disease from developing in patients with mild-to-moderate symptoms.

The drug is given as a one-time treatment through an IV. The FDA allowed its use in adults and children 12 and over who weigh at least 88 pounds (40 kilograms) and who are at high risk of severe illness from COVID-19 because of age or certain other medical conditions.

Emergency authorisation allows use of the drug to start while studies are continuing to establish safety and effectiveness. Early results suggest the drug may reduce COVID-19-related hospitalisation or emergency room visits in patients at high risk for disease progression, the FDA said.

Regeneron said that initial doses will be made available to roughly 300,000 patients through a federal government allocation program. Patients will not be charged for the drug but may have to pay part of the cost of giving the IV. Initial supplies will likely be vastly outstripped by demand as the U.S. has surged past 10 million reported cases, with the country facing what health experts say will be a dark winter due uncontrolled spread of the virus.

Antibodies are proteins the body makes to target and help eliminate viruses, but it can take weeks for the best ones to form after an infection occurs. The drugs are concentrated versions of ones that proved best able to do this in lab and animal tests, and in theory help the body start to fight the virus right away.

The Regeneron drug is a combo of two antibodies to enhance the chances it will prove effective. Earlier this month, the FDA gave emergency authorization to a single-antibody drug from Eli Lilly that also is still being studied.

There’s no way to know whether the Regeneron drug helped Trump recover; he received a host of treatments and most COVID-19 patients recover on their own. FDA regulators authorized the Regeneron drug using their emergency powers to quickly speed the availability of experimental drugs and other medical products during public health crises.

In normal times the FDA requires “substantial evidence” to show that a drug is safe and effective, usually through one or more large, rigorously controlled patient studies. But during public health emergencies the agency can lower those standards and require only that an experimental treatment’s potential benefits outweigh its risks.

The emergency authorization functions like a temporary approval for the duration of the COVID-19 pandemic. To win full approval, Regeneron will have to submit additional research to fully define the drug’s safety and benefit for patients.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

India to provide assistance to the families of two Indians killed in UAE: Envoy

SC to consider hearing plea seeking disclosure of criminal background of candidates before polls

Belagavi: Bommai seeks report in case related to death of three babies

Illegal sand mining: ED raids multiple locations in Punjab

PM Modi is incarnation of God like Lord Ram and Lord Krishna born to end despair: MP minister

Beltangady: Two killed in road mishap

India reports 2.38 lakh new Covid cases, 310 more deaths


Related Articles More

India to provide assistance to the families of two Indians killed in UAE: Envoy

“This sinful targeting…”: UAE’s stern warning after drone attack kills 3

Unlikely that people will move around with masks on forever: Fauci on ‘new normal’

Out of this world: 555.55-carat black diamond lands in Dubai

Imran Khan speaks to Vladimir Putin; praises Russian president for ’emphatic statement’ against Islamophobia

MUST WATCH

Night Curfew : Shops, stall will close before 10pm(jan 17)

NEWS BULLETIN 17-01-2022

THE HISTORY OF KRISHNAPURA MUTT SWAMIJI

DOCTOR BEATS UP A VEGETABLE VENDOR

Vidyasagara Teertha Swamiji Paryaya Message


Latest Additions

India to provide assistance to the families of two Indians killed in UAE: Envoy

Time is muscle, do not delay heart failure treatment

Priyanka slams Yogi govt, urges youth to stick to agenda of employment, education in polls

SC to consider hearing plea seeking disclosure of criminal background of candidates before polls

Muslim groom dressed as Koragajja case: Miscreants pelt stones at youth’s house

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.